These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 15538936)

  • 21. Prevalence of unwillingness to use insulin therapy and its associated attitudes amongst patients with Type 2 diabetes in Saudi Arabia.
    Batais MA; Schantter P
    Prim Care Diabetes; 2016 Dec; 10(6):415-424. PubMed ID: 27297805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of depression and its associations with cardio-metabolic control in Aboriginal and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Davis TM; Hunt K; Bruce DG; Starkstein S; Skinner T; McAullay D; Davis WA
    Diabetes Res Clin Pract; 2015 Mar; 107(3):384-91. PubMed ID: 25656760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.
    Chaillous L; Bouhanick B; Kerlan V; Mathieu E; Lecomte P; Ducluzeau PH; Delamaire M; Sonnet E; Maugendre D; Maréchaud R; Rohmer V; Saï P; Charbonnel B
    Diabetes Metab; 2010 Feb; 36(1):64-70. PubMed ID: 20060765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-cell deterioration determines the onset and rate of progression of secondary dietary failure in type 2 diabetes mellitus: the 10-year follow-up of the Belfast Diet Study.
    Levy J; Atkinson AB; Bell PM; McCance DR; Hadden DR
    Diabet Med; 1998 Apr; 15(4):290-6. PubMed ID: 9585393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
    Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
    Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and type 2 diabetes: Action LADA 9 [corrected].
    Juhl CB; Bradley U; Holst JJ; Leslie RD; Yderstraede KB; Hunter S;
    Diabet Med; 2014 Aug; 31(8):941-5. PubMed ID: 24628669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus.
    Spoelstra JA; Stolk RP; Cohen D; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    J Clin Psychiatry; 2004 May; 65(5):674-8. PubMed ID: 15163254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in retinopathy prevalence and progression between Anglo-Celt and Aboriginal Australians: the Fremantle Diabetes Study Phase II.
    Drinkwater JJ; Davis WA; Turner AW; McAullay D; Davis TME
    Intern Med J; 2022 Apr; 52(4):590-598. PubMed ID: 33040394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Intervention in Type 2 Diabetes Mellitus - A Pathophysiologically Reasoned Approach?
    Forst T; Heise T; Plum-Morschel L
    Curr Diabetes Rev; 2016; 12(4):429-439. PubMed ID: 27296043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with psychological insulin resistance in individuals with type 2 diabetes.
    Nam S; Chesla C; Stotts NA; Kroon L; Janson SL
    Diabetes Care; 2010 Aug; 33(8):1747-9. PubMed ID: 20435797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and outcome of type 2 diabetes in urban Aboriginal people: the Fremantle Diabetes Study.
    Davis TM; McAullay D; Davis WA; Bruce DG
    Intern Med J; 2007 Jan; 37(1):59-63. PubMed ID: 17199846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective memory slips are associated with forgetting to take glucose-lowering therapies among adults with diabetes: results from the second Diabetes MILES - Australia (MILES-2) survey.
    Trawley S; Baptista S; Pouwer F; Speight J
    Diabet Med; 2019 May; 36(5):569-577. PubMed ID: 30511764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase II.
    Yarash T; Sharif I; Masood F; Clifford RM; Davis WA; Davis TME
    Intern Med J; 2020 Aug; 50(8):944-950. PubMed ID: 31314167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Pharmacological Treatment of Type 2 Diabetes Mellitus in Undocumented Migrants: Is It Appropriate for the Phenotype of the Disease?
    Fiorini G; Cortinovis I; Corrao G; Franchi M; Pincelli AI; Perotti M; Rigamonti AE; Sartorio A; Cella SG
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33167380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum uric acid does not predict cardiovascular or all-cause mortality in type 2 diabetes: the Fremantle Diabetes Study.
    Ong G; Davis WA; Davis TM
    Diabetologia; 2010 Jul; 53(7):1288-94. PubMed ID: 20349345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater use of insulin by southern European compared with Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Cull CA; Bruce DG; Batty KT; Davis TM
    Eur J Endocrinol; 2004 Nov; 151(5):579-86. PubMed ID: 15538936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in characteristics and management of Asian and Anglo-Celts with type 2 diabetes over a 15-year period in an urban Australian community: The Fremantle Diabetes Study.
    Tan ED; Davis WA; Davis TM
    J Diabetes; 2016 Jan; 8(1):139-47. PubMed ID: 25581285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E genotype and mortality in Southern European and Anglo-Celt patients with type 2 diabetes: the Fremantle Diabetes Study.
    Davis WA; Chin E; Jee A; Martins J; Bruce DG; Beilby J; Davis TM
    Eur J Endocrinol; 2010 Oct; 163(4):559-64. PubMed ID: 20693183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuing disparities in cardiovascular risk factors and complications between aboriginal and Anglo-Celt Australians with type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM; Hunt K; McAullay D; Chubb SA; Sillars BA; Bruce DG; Davis WA
    Diabetes Care; 2012 Oct; 35(10):2005-11. PubMed ID: 22815295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.